The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysis (Q26829026)

Zhongsu Wang

2

1 reference

Yong Zhang

3

1 reference

Xiangcui Yin

4

1 reference

Yinglong Hou

5

1 reference

language of work or name

1 reference

July 2015

1 reference

1 reference

17

1 reference

issue

7

1 reference

page(s)

1076-84

1 reference

Patients with pacemaker or implantable cardioverter-defibrillator

cites work

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Updates in antiplatelet agents used in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Current atrial fibrillation guidelines and therapy algorithms: are they adequate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Pacemaker or defibrillator surgery without interruption of anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

No Increased Bleeding Events with Continuation of Oral Anticoagulation Therapy for Patients Undergoing Cardiac Device Procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Anticoagulation bridging around device surgery: compliance with guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Implantation of cardiac rhythm devices during concomitant anticoagulation or antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Meta-analysis of bleeding complications associated with cardiac rhythm device implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Methodological index for non-randomized studies (minors): development and validation of a new instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Risk of hematoma complications after device implant in the clopidogrel era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Antithrombotic or anti-platelet agents in patients undergoing permanent pacemaker implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

The mechanism of action of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Is antiarrhythmia device implantation safe under dual antiplatelet therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

In vitro effects of clopidogrel on the platelet-subendothelium interaction, platelet thromboxane and endothelial prostacyclin production, and nitric oxide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Evaluation of Early Complications Related to De Novo Cardioverter Defibrillator Implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Pacemaker infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

Influence of oral antiplatelet therapy on hemorrhagic complications of pacemaker implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

7 January 2021

Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

7 January 2021

Hematoma complicating permanent pacemaker implantation: the role of periprocedural antiplatelet or anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

7 January 2021

Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

7 January 2021

Implantable defibrillation: eight years clinical experience

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

7 January 2021

Oral anticoagulation continuation compared with heparin bridging therapy among high risk patients undergoing implantation of cardiac rhythm devices: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093/EUROPACE/EUU369

7 January 2021

release_utkodsy5ifbmjcawtanzxskl3e

Identifiers

DOI

10.1093/EUROPACE/EUU369

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/utkodsy5ifbmjcawtanzxskl3e

24 November 2022

mapped directly with Wikidata item

PubMed publication ID

25713013

1 reference